A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer

Oncologist

Volumn 9, Issue 6, 2004, Pages 665-672

  Huncharek, Michael ^a,b   McGarry, Ronald ^c  

^a MARSHFIELD CLINIC   (United States)

^b Meta Analysis Research Group   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Combined modality therapy; Lung cancer; Thoracic radiation

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; NITROSOUREA DERIVATIVE; VINDESINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG SAFETY; DRUG TOXICITY; HUMAN; LUNG SMALL CELL CANCER; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SURVIVAL TIME; SYSTEMATIC REVIEW; THORAX; TIME SERIES ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 9244240966     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-6-665     Document Type: Article

References (33)

1. American Joint Committee on Cancer. Cancer staging manual, 4th ed. In: Fleming I, ed. Philadelphia: Lippincott, 1997:127-137.
2. Ihde DH. Chemotherapy of lung cancer. N Engl J Med 1992;327:1434-1441.
3. Bunn PA Jr, Lichter AS, Makuch RW et al. Chemotherapy alone or chemotherapy with chest irradiation therapy in limited stage small cell lung cancer: a prospective randomized trial. Ann Intern Med 1987;106:655-662.
4. Perez CA, Einhom L, Oldham RK et al. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. J Clin Oncol 1984;2:1200-1208.
5. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;6:890-895.
6. Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992;13:327:1618-1624.
7. Tsukada H, Yokoyama A, Goto K et al. Concurrent versus sequential radiotherapy for small cell lung cancer. Semin Oncol 2001;28:23-26.
8. The Handbook of Research Synthesis. In: Cooper H, Hedges LV, eds. New York: Russell Sage Foundation, 1994:37-70.
9. Yusuf S, Peto R, Lewis J et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
10. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine, 2nd ed. New York: Oxford University Press, New York, 2000:80-91.
11. Goto K, Nishiwaki Y, Takada M et al. Final results of a phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: The Japanese Clinical Oncology Group Study. Proc Am Soc Clin Oncol 1999;18:468a.
12. Jeremic B, Shibamoto Y, Acimovic L et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited stage small-cell lung cancer: a randomized study. J Clin Oncol 1997;15:893-900.
13. Lebeau B, Urban T, Brechot JM et al. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. Cancer 1999;86:1480-1487.
14. Murray N, Coy P, Pater JL et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993;11:336-344.
15. Perry MC, Herndon JE 3rd, Eaton WL et al. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B study 8083. J Clin Oncol 1998;16:2466-2467.
16. Skarlos DV, Samantas E, Briassoulis E et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2001;12:1231-1238.
17. Takada M, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limted-stage small cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3054-3060.
18. Work E, Nielsen OS, Bentzen SM et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small cell lung cancer. J Clin Oncol 1997;15:3030-3037.
19. Bonner JA, Sloan JA, Shanahan TG et al. Phase III comparison of twice-daily irradiation for patients with limited stage small-call lung carcinoma. J Clin Oncol 1999;17:2681-2691.
20. Perry MC, Eaton WL, Popert KJ et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-918.
21. Schultz HP, Nielsen OS, Sell et al. Timing of chest irradiation with respect to combination chemotherapy in small-cell lung cancer, limited disease. Lung Cancer 1988;4:A153-A159.
22. Gregor A, Drings P, Burghouts J et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997;15:2840-2849.
23. Murray N. Treatment of small cell lung cancer: the state of the art. Lung Cancer 1997;1(suppl 1):S75-S89.
24. Arriagada R, LeChevalier T, Baldeyrou P et al. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 1985;11:1461-1467.
25. Tsukada H, Yokoyama A, Goto K et al. Concurrent versus sequential radiotherapy for small cell lung cancer. Semin Oncol 2001;28:23-26.
26. Osterlind K, Ihde DC, Ettinger DS et al. Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep 1983;67:3-9.
27. Matthews MJ. Problems in morphology and behavior of bronchopulmonary malignant disease. In: Israel L, Chahinian AP, eds. Lung Cancer: Natural History, Prognosis and Therapy. New York: Academic Press, 1976:23-28.
28. Curran WJ. Combined-modality therapy for limited-stage small cell lung cancer. Semin Oncol 2001;28(suppl 4):14-22.
29. Turrisi AT 3rd, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etopside. N Engl J Med 1999;340:265-271.
30. Turrisi AT, Sherman CA. The treatment of limited small cell lung cancer: a report of the progress made and future prospects. Eur J Cancer 2002;38:279-291.
31. Meert AP, Paesmans M, Berghmans T et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001;1:5.
32. Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;12;341:476-484.
33. Tai TH, Yu E, Dickof P et al. Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:68-74.